Events

All members have the option of attending our various HTC-centric events which include:

  • Two in-person member meetings a year (in spring and fall)
  • Regular Webinars educating our members on HTC operations & organizational management, payer relations, regulations and legal updates, and advocacy

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Pfizer – Exploring the Science and Possibilities of Gene Therapy in Hemophilia

Date: Thursday, March 14, 2024 Time: 1:00pm - 2:00pm ET TITLE: Exploring the Science and Possibilities of Gene Therapy in Hemophilia WEBINAR OVERVIEW: By attending this webinar, you will discover the scientific approach of gene therapy, understand gene therapy objectives for patients with hemophilia, and explore the shared decision-making process to accompany your patients in Read the full article...

🟥 Member Event : 2024 New HTC Staff Orientation

Date: March 25 - 27 Location: TBD PLEASE NOTE REGISTRATION FOR THIS MEETING WILL CLOSE ON FEBRUARY 9, 2024. Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.

🟥 Member Event : 2024 Spring Members Meeting & Hemophilia Alliance Hill Day

Date: April 15 - 18 Location: Washington, DC Monday 4/15 – Welcome Reception Tuesday 4/16 – Spring Members Meeting Wednesday 4/17 – Spring Members Meeting, Hill Day Training and Joe’s Retirement Party Thursday 4/18 – Hemophilia Alliance Hill Day Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Genentech – Reinforcing 10+ years of clinical trial experience with a subcutaneous prophylaxis treatment

Date: Tuesday, May 7, 2024 Time: 2:00pm - 3:00pm ET TITLE: Reinforcing 10+ years of clinical trial experience with a subcutaneous prophylaxis treatment, including the latest data in infants WEBINAR OBJECTIVE: Dr. Mike Silvey will share his perspective on managing patients with hemophilia A using a subcutaneous prophylactic treatment. The presentation will include the pivotal Read the full article...